CN114470067B - Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof - Google Patents
Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof Download PDFInfo
- Publication number
- CN114470067B CN114470067B CN202210231494.9A CN202210231494A CN114470067B CN 114470067 B CN114470067 B CN 114470067B CN 202210231494 A CN202210231494 A CN 202210231494A CN 114470067 B CN114470067 B CN 114470067B
- Authority
- CN
- China
- Prior art keywords
- extract
- water
- chinese medicine
- parts
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了一种治疗静脉炎的中药复方及其制备方法与应用,属于中药技术领域,所述中药复方由以下重量份的原料组成:马铃薯100~150份,黄连3~10份,大黄10~20份,冰片1~5份。本发明的治疗静脉炎的中药复方,具有“消肿止痛,清热解毒,化瘀通经”的功效。与传统方法相比,本发明的中药复方对治疗化疗性和/或机械性静脉炎的有效率高达100%、见效快、无不良反应、患者的依从性好、价格低廉,能够有效地预防与治疗化疗性和/或机械性静脉炎,同时本发明的制备简便易得。
The invention provides a traditional Chinese medicine compound for treating phlebitis and its preparation method and application, belonging to the technical field of traditional Chinese medicine. The traditional Chinese medicine compound is composed of the following raw materials in parts by weight: 100-150 parts of potatoes, 3-10 parts of rhubarb, and 10 parts of rhubarb ~20 parts, borneol 1~5 parts. The traditional Chinese medicine compound for treating phlebitis of the present invention has the effects of "reducing swelling and alleviating pain, clearing heat and detoxification, removing blood stasis and stimulating menstruation". Compared with traditional methods, the Chinese medicine compound of the present invention has an effective rate of up to 100% in the treatment of chemotherapy and/or mechanical phlebitis, quick results, no adverse reactions, good patient compliance, and low price, and can effectively prevent and treat phlebitis with It can treat chemotherapeutic and/or mechanical phlebitis, and the preparation of the invention is simple and easy to obtain.
Description
技术领域technical field
本发明涉及中药技术领域,具体涉及一种治疗静脉炎的中药复方及其制备方法与应用。The invention relates to the technical field of traditional Chinese medicines, in particular to a compound traditional Chinese medicine for treating phlebitis and its preparation method and application.
背景技术Background technique
静脉炎指静脉血管的急性无菌性炎症,属于临床常见病和多发病。药物化疗是癌症治疗的重要方法,主要以静脉方式给药,但化疗药物往往具有较强的刺激性与毒副作用,长期给药后容易引起血管药物性损伤,导致化疗性静脉炎的产生。据统计,我国静脉输液工具中留置针占比大于90%,而留置针相关并发症中最为常见的即是静脉炎。由于很多患者需要大剂量长时间的静脉输液,再加上血管脆性变大、留置针保留时间较长等因素,都有可能造成机械性静脉炎的发生,其发生率为2.5%~45%。患者发生不同程度的静脉炎后,沿浅静脉出现条索状红线,由于局部组织出现红肿、疼痛、灼热与硬结,甚至血管硬化闭塞与局部组织坏死等,直接导致药物输入困难,非常不利于治疗,同时也会增加血栓形成风险,增加患者生理和心理痛苦。Phlebitis refers to acute aseptic inflammation of venous blood vessels, which is a common clinical disease and frequently-occurring disease. Drug chemotherapy is an important method of cancer treatment, mainly administered intravenously, but chemotherapy drugs often have strong irritation and side effects, and long-term administration can easily cause drug-induced damage to blood vessels, leading to chemotherapy-induced phlebitis. According to statistics, indwelling needles account for more than 90% of intravenous infusion tools in my country, and phlebitis is the most common complication related to indwelling needles. Because many patients need large doses of intravenous infusion for a long time, coupled with factors such as increased vascular fragility and long retention time of indwelling needles, mechanical phlebitis may occur, and the incidence rate is 2.5% to 45%. After patients with varying degrees of phlebitis, cord-like red lines appear along the superficial veins, redness, swelling, pain, burning and induration in local tissues, and even vascular sclerosis and occlusion and local tissue necrosis, which directly lead to difficulty in drug infusion, which is very unfavorable for treatment At the same time, it will increase the risk of thrombosis and increase the physical and psychological pain of patients.
近年来,静脉炎逐渐受到广泛重视,但治疗与护理方法仍存在一定的滞后性。临床中常见治疗方法包括硫酸镁湿敷,中药饮片熬成药膏外敷,马铃薯切片等,通过软膏剂、热敷袋/包、糊剂、喷剂或纱布浸药湿敷等外用疗法,但药物治疗效果既无法得到有效保障,还存在操作不便、换药次数频繁、易污染衣物、无统一规范、价格昂贵、技术含量低、体感差等问题,且上述部分治疗方法还需要一些红外线照射与理疗等所需的特定仪器,操作繁琐,携带不便,还严重影响患者的正常活动与生活。In recent years, phlebitis has gradually received widespread attention, but there is still a certain lag in treatment and nursing methods. Common treatment methods in clinical practice include magnesium sulfate wet compress, external application of ointment boiled from Chinese herbal medicine pieces, potato slices, etc. External therapy such as ointment, hot compress bag/package, paste, spray or gauze soaked medicine wet compress, etc., but the therapeutic effect of the drug It cannot be effectively guaranteed, and there are also problems such as inconvenient operation, frequent dressing changes, easy to contaminate clothes, no unified standard, high price, low technical content, poor body sensation, etc., and some of the above treatment methods also need some infrared radiation and physical therapy. The specific instruments needed are cumbersome to operate, inconvenient to carry, and seriously affect the normal activities and lives of patients.
中医理论认为静脉炎是因反复穿刺、药物刺激等问题导致的血液循环障碍,且在血瘀、血管充血等状态下,使热量出现积聚现象,诱发皮肤组织血液溢出,肉眼可见局部发红状况。但中药治疗后往往奏效缓慢,操作复杂,目前还尚无安全有效、便于携带、操作简便、见效快的中药复方。The theory of traditional Chinese medicine believes that phlebitis is a blood circulation disorder caused by repeated punctures, drug stimulation, etc., and in the state of blood stasis, vascular congestion, etc., heat will accumulate, causing blood overflow in the skin tissue, and local redness can be seen with the naked eye. However, after the treatment of traditional Chinese medicine, it often takes effect slowly and the operation is complicated. At present, there is no Chinese medicine compound that is safe and effective, easy to carry, easy to operate, and quick to take effect.
发明内容Contents of the invention
本发明的目的在于提供一种治疗静脉炎的中药复方及其制备方法与应用,本发明的中药复方具有“消肿止痛,清热解毒,化瘀通经”的功效,对化疗性静脉炎和机械性静脉炎具有良好的预防与治疗作用。The object of the present invention is to provide a Chinese medicine compound for treating phlebitis and its preparation method and application. Sexual phlebitis has good preventive and therapeutic effects.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
本发明提供了一种治疗静脉炎的中药复方,由以下重量份的原料组成:马铃薯100~150份,黄连3~10份,大黄10~20份,冰片1~5份。The invention provides a traditional Chinese medicine compound prescription for treating phlebitis, which consists of the following raw materials in parts by weight: 100-150 parts of potatoes, 3-10 parts of berberine, 10-20 parts of rhubarb and 1-5 parts of borneol.
优选地,所述中药复方由以下重量份的原料组成:马铃薯110~140份,黄连4~9份,大黄13~18份,冰片2~4.5份。Preferably, the traditional Chinese medicine compound recipe is composed of the following raw materials in parts by weight: 110-140 parts of potatoes, 4-9 parts of berberine, 13-18 parts of rhubarb, and 2-4.5 parts of borneol.
本发明还提供了上述任意一种中药复方的制备方法,包括以下步骤:The present invention also provides a preparation method of any one of the above-mentioned Chinese medicine compounds, comprising the following steps:
分别将马铃薯、黄连、大黄粉碎,与水混合后提取,即得马铃薯提取物、黄连提取物或大黄提取物;Pulverize potatoes, rhubarb and rhubarb respectively, mix with water and extract to obtain potato extract, rhubarb extract or rhubarb extract;
将冰片粉碎,与无水乙醇混合,过滤取滤液,即得冰片溶解液;Crush the borneol, mix it with absolute ethanol, filter and take the filtrate, and obtain the borneol solution;
将马铃薯提取物、黄连提取物、大黄提取物和冰片溶解液混合后,即得中药复方。After mixing the potato extract, the rhubarb extract, the rhubarb extract and the borneol dissolving solution, the traditional Chinese medicine compound is obtained.
优选地,所述马铃薯提取物的制备包括如下步骤:Preferably, the preparation of the potato extract comprises the following steps:
将马铃薯粉碎后与水混合,所述马铃薯与水的质量体积比为1:5~7,于90~100℃提取25~35min,提取1~3次。The potatoes are crushed and mixed with water, the mass volume ratio of the potatoes and water is 1:5-7, and extracted at 90-100° C. for 25-35 minutes, 1-3 times.
优选地,所述黄连提取物的制备包括如下步骤:Preferably, the preparation of the Coptidis Rhizome extract comprises the following steps:
将黄连粉碎后与水混合,所述黄连与水的质量体积比为1:8~12,于90~100℃提取45~75min,提取1~3次。Coptidis rhizome is crushed and mixed with water, the mass volume ratio of the rhizome to water is 1:8-12, extracted at 90-100° C. for 45-75 min, 1-3 times.
优选地,所述大黄提取物的制备包括如下步骤:Preferably, the preparation of the rhubarb extract comprises the following steps:
将大黄粉碎后与水混合,所述大黄与水的质量体积比为1:9~11,于90~100℃提取50~70min,提取1~3次。The rhubarb is pulverized and mixed with water, the mass volume ratio of the rhubarb to water is 1:9-11, extracted at 90-100° C. for 50-70 min, and extracted 1-3 times.
优选地,所述冰片与无水乙醇的质量体积比为1:7~13。Preferably, the mass volume ratio of the borneol to absolute ethanol is 1:7-13.
本发明还提供了上述任意一种中药复方在制备治疗静脉炎药物中的应用。The present invention also provides the application of any one of the above-mentioned traditional Chinese medicine compounds in the preparation of medicines for treating phlebitis.
优选地,所述静脉炎包括化疗性静脉炎和/或机械性静脉炎。Preferably, said phlebitis comprises chemotherapy phlebitis and/or mechanical phlebitis.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明治疗静脉炎的中药复方,具有“消肿止痛,清热解毒,化瘀通经”的功效。与传统方法相比,本发明的中药复方对治疗化疗性静脉炎和机械性静脉炎的有效率高达100%、见效快、无不良反应、患者的依从性好、价格低廉,能够有效地预防与治疗化疗性静脉炎和机械性静脉炎,同时本发明的制备简便易得。本发明既解决了传统药物外敷的治疗成本高、不良反应较大、使用不便、依从性差等问题,还解决了一些疗法需要红外线照射与理疗等所需特定仪器以及操作步骤繁琐等问题。The traditional Chinese medicine compound for treating phlebitis has the effects of "reducing swelling and relieving pain, clearing away heat and detoxification, removing blood stasis and stimulating menstrual flow". Compared with traditional methods, the Chinese medicine compound of the present invention has an effective rate of up to 100% for the treatment of chemotherapeutic phlebitis and mechanical phlebitis, quick results, no adverse reactions, good patient compliance, low price, and can effectively prevent and treat phlebitis with It can treat chemotherapeutic phlebitis and mechanical phlebitis, and the preparation of the invention is simple and easy to obtain. The invention not only solves the problems of high treatment cost, large adverse reactions, inconvenient use, and poor compliance of traditional external application of medicines, but also solves the problems that some treatments require specific instruments such as infrared irradiation and physiotherapy, and cumbersome operating steps.
附图说明Description of drawings
图1为贴敷实施例1的中药复方水凝胶前后的治疗情况对比图,其中框图中为贴敷部位。Fig. 1 is a comparison diagram of the treatment situation before and after applying the traditional Chinese medicine compound hydrogel of Example 1, wherein the block diagram is the application site.
具体实施方式Detailed ways
本发明提供了一种治疗静脉炎的中药复方,由以下重量份的原料组成:马铃薯100~150份,黄连3~10份,大黄10~20份,冰片1~5份。The invention provides a traditional Chinese medicine compound prescription for treating phlebitis, which consists of the following raw materials in parts by weight: 100-150 parts of potatoes, 3-10 parts of berberine, 10-20 parts of rhubarb and 1-5 parts of borneol.
在本发明中,所述中药复方优选地由以下重量份的原料组成:马铃薯110~140份,黄连4~9份,大黄13~18份,冰片2~4.5份。In the present invention, the traditional Chinese medicine compound is preferably composed of the following raw materials in parts by weight: 110-140 parts of potatoes, 4-9 parts of berberine, 13-18 parts of rhubarb, and 2-4.5 parts of borneol.
在本发明中,马铃薯为君药,解毒消肿止痛;黄连清热解毒,大黄凉血解毒,逐瘀通经共为臣药;冰片清热止痛为佐药,全方共奏消肿止痛,清热解毒,化瘀通经之功效。本发明的中药复方是在民间常用马铃薯切片外敷以消肿止痛的基础上进行了改进,经临床反复验证,对机械性和化疗性静脉炎的治疗的有效率高达100%。本发明对马铃薯、黄连、大黄、冰片的来源没有限定,采用本领域公知的市售产品即可。In the present invention, potato is the king drug, detoxifying, reducing swelling and relieving pain; Coptis chinensis is heat-clearing and detoxifying, rhubarb cooling blood is detoxifying, removing blood stasis and dredging menstrual flow is a ministerial drug altogether; , the effect of removing blood stasis and promoting menstruation. The traditional Chinese medicine compound prescription of the present invention is improved on the basis of external application of potato slices commonly used by folks to reduce swelling and relieve pain. After repeated clinical verification, the effective rate of treating mechanical and chemotherapeutic phlebitis is as high as 100%. The present invention does not limit the sources of potatoes, rhubarb, borneol, and commercially available products known in the art can be used.
本发明提供了上述任意一种中药复方的制备方法,包括以下步骤:The present invention provides the preparation method of above-mentioned any one Chinese medicine compound, comprises the following steps:
分别将马铃薯、黄连、大黄粉碎,与水混合后提取,即得马铃薯提取物、黄连提取物或大黄提取物;Pulverize potatoes, rhubarb and rhubarb respectively, mix with water and extract to obtain potato extract, rhubarb extract or rhubarb extract;
将冰片粉碎,与无水乙醇混合,过滤取滤液,即得冰片溶解液;Crush the borneol, mix it with absolute ethanol, filter and take the filtrate, and obtain the borneol solution;
将马铃薯提取物、黄连提取物、大黄提取物和冰片溶解液混合后,即得中药复方。After mixing the potato extract, the rhubarb extract, the rhubarb extract and the borneol dissolving solution, the traditional Chinese medicine compound is obtained.
在本发明中,所述马铃薯提取物的制备优选地包括如下步骤:将马铃薯粉碎后与水混合,所述马铃薯与水的质量体积比为1:5~7,于90~100℃提取25~35min,提取1~3次;所述马铃薯提取物的制备更优选地包括如下步骤:将马铃薯粉碎后与水混合,所述马铃薯与水的质量体积比为1:6,于100℃提取30min,提取2次。In the present invention, the preparation of the potato extract preferably includes the following steps: crush the potato and mix it with water, the mass volume ratio of the potato to water is 1:5-7, extract at 90-100°C for 25- 35min, extracting 1-3 times; the preparation of the potato extract more preferably includes the following steps: crushing the potato and mixing with water, the mass volume ratio of the potato and water is 1:6, extracting at 100°C for 30min, Extract 2 times.
所述黄连提取物的制备优选地包括如下步骤:将黄连粉碎后与水混合,所述黄连与水的质量体积比为1:8~12,于90~100℃提取45~75min,提取1~3次。所述黄连提取物的制备更优选地包括如下步骤:将黄连粉碎后与水混合,所述黄连与水的质量体积比为1:10,于100℃提取60min,提取2次。The preparation of the Coptis chinensis extract preferably includes the following steps: crush the Coptis chinensis and mix it with water, the mass volume ratio of the Coptis chinensis and water is 1:8-12, extract at 90-100° C. for 45-75 minutes, and extract for 1-20 minutes. 3 times. The preparation of the Coptis chinensis extract more preferably includes the following steps: crushing the Coptis chinensis and mixing it with water, the mass volume ratio of the Coptis chinensis and water is 1:10, extracting at 100° C. for 60 min, twice.
所述大黄提取物的制备优选地包括如下步骤:将大黄粉碎后与水混合,所述大黄与水的质量体积比为1:9~11,于90~100℃提取50~70min,提取1~3次。所述大黄提取物的制备更优选地包括如下步骤:将大黄粉碎后与水混合,所述大黄与水的质量体积比为1:10,于100℃提取60min,提取2次。The preparation of the rhubarb extract preferably includes the following steps: crush the rhubarb and mix it with water, the mass volume ratio of the rhubarb to water is 1:9-11, extract at 90-100°C for 50-70min, extract for 1- 3 times. The preparation of the rhubarb extract more preferably includes the following steps: crush the rhubarb and mix it with water, the mass volume ratio of the rhubarb to water is 1:10, extract at 100°C for 60 min, and extract twice.
所述冰片与无水乙醇的质量体积比优选为1:7~13,更优选为1:10。The mass volume ratio of the borneol to absolute ethanol is preferably 1:7-13, more preferably 1:10.
上述的制备得到的马铃薯提取物、黄连提取物、大黄提取物还包括浓缩、过滤,所述浓缩优选地采用65℃下减压浓缩至1/10,所述过滤优选地采用0.22μm陶瓷膜过滤。本发明将马铃薯、大黄、黄连分别提取后混合,可以有效地防止马铃薯与其他中药原料混合提取时成分之间发生反应使其药理活性的丧失。The potato extract, coptis extract and rhubarb extract prepared above also include concentration and filtration, the concentration is preferably concentrated to 1/10 under reduced pressure at 65°C, and the filtration is preferably 0.22 μm ceramic membrane filtration . The invention extracts the potato, rhubarb and coptis separately and then mixes them, which can effectively prevent the reaction between the components when the potato and other traditional Chinese medicine raw materials are mixed and extracted so that the pharmacological activity is lost.
本发明还提供了上述任意一种中药复方在制备治疗静脉炎药物中的应用。The present invention also provides the application of any one of the above-mentioned traditional Chinese medicine compounds in the preparation of medicines for treating phlebitis.
在本发明中,所述的药物包括以中药复方为活性成分及药学上可接受的载体,所述的药物可制成水凝胶、水凝乳、膏药贴、喷雾剂、软膏、乳膏、糊膏、涂膜剂,所述的药物以外敷施用。其中中药复方水凝胶的制备方法如下:In the present invention, the medicine includes Chinese medicine compound as an active ingredient and a pharmaceutically acceptable carrier, and the medicine can be made into hydrogel, water curd, plaster, spray, ointment, cream, Paste, coating, the medicine is applied externally. Wherein the preparation method of Chinese medicine compound hydrogel is as follows:
配制相1:甘羟铝0.14%、NOVETAC P55N 0.5%、EDTA 0.12%、NOVETAC P46N 5%,甘油25%;Preparation Phase 1: Aluminum Glycol 0.14%, NOVETAC P55N 0.5%, EDTA 0.12%, NOVETAC P46N 5%, Glycerin 25%;
配制相2:石酒酸0.22%、DMDMH 0.2%、纯净水50%;Preparation phase 2: tartaric acid 0.22%, DMDMH 0.2%, purified water 50%;
配制相3:酒精0.45%、薄荷脑0.25%;Preparation phase 3: 0.45% alcohol, 0.25% menthol;
配制相4:本发明的中药复方余量。Preparation phase 4: the remaining amount of the compound Chinese medicine of the present invention.
将配制相2与配制相4混合均匀后加入配制相1,搅拌均匀,然后加入配制相3,快速搅拌形成胶体,完成后进入涂布机制成水凝胶贴备用。Mix the preparation phase 2 and the preparation phase 4 evenly, then add the preparation phase 1, stir evenly, then add the preparation phase 3, stir quickly to form a colloid, and enter the coating machine to make a hydrogel paste for later use.
在本发明中,若无特殊说明,所有的原料组分均为本领域技术人员熟知的市售商品。In the present invention, unless otherwise specified, all raw material components are commercially available products well known to those skilled in the art.
下面将结合本发明中的实施例,对本发明中的技术方案进行清楚、完整地描述。显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例1Example 1
一种治疗静脉炎的中药复方,由以下重量份的原料组成:马铃薯100g,黄连10g,大黄15g,冰片1g。A compound traditional Chinese medicine for treating phlebitis, which consists of the following raw materials in parts by weight: 100g of potatoes, 10g of berberine, 15g of rhubarb and 1g of borneol.
所述中药复方的制备方法,具体步骤如下:The preparation method of described Chinese medicine compound, concrete steps are as follows:
将上述马铃薯粉碎后与600mL水混合,于100℃提取30min,过滤得提取液和马铃薯渣,然后将马铃薯渣按照上述操作重复提取1次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得马铃薯提取物;Crush the above potatoes and mix with 600mL of water, extract at 100°C for 30min, filter to obtain the extract and potato residue, then repeat the extraction of the potato residue once according to the above operation, combine the extract, and then concentrate the extract under reduced pressure at 65°C To 1/10, filter the filtrate through a 0.22μm ceramic membrane to obtain the potato extract;
将上述黄连粉碎后与100mL水混合,于100℃提取60min,过滤得提取液和黄连渣,然后将黄连渣按照上述操作重复提取1次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得黄连提取物;Crush the Coptidis rhizome above and mix it with 100mL of water, extract at 100°C for 60min, filter to obtain the extract and Coptis chinensis residue, then repeat the extraction of the Coptis chinensis residue once according to the above operation, combine the extracts, and then concentrate the extract under reduced pressure at 65°C To 1/10, filter through a 0.22μm ceramic membrane to get the filtrate to obtain the Coptidis Rhizome extract;
将上述大黄粉碎后与150mL水混合,于100℃提取60min,过滤得提取液和大黄渣,然后将大黄渣按照上述操作重复提取1次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得大黄提取物;Grind the above rhubarb and mix it with 150mL of water, extract at 100°C for 60min, filter to obtain the extract and rhubarb residue, then repeat the extraction of the rhubarb residue once according to the above operation, combine the extract, and then concentrate the extract under reduced pressure at 65°C To 1/10, filter the filtrate through a 0.22μm ceramic membrane to obtain the rhubarb extract;
将上述冰片粉碎,与10mL无水乙醇混合溶解,经0.22μm陶瓷膜过滤取滤液,即得冰片溶解液;Crush the above-mentioned borneol, mix and dissolve it with 10 mL of absolute ethanol, filter through a 0.22 μm ceramic membrane to obtain the filtrate, and obtain the borneol solution;
将上述马铃薯提取物、黄连提取物、大黄提取物和冰片溶解液混合后,即得中药复方。After mixing the potato extract, rhubarb extract, rhubarb extract and borneol dissolving solution, the traditional Chinese medicine compound is obtained.
实施例2Example 2
一种治疗静脉炎的中药复方,由以下重量份的原料组成:马铃薯120g,黄连5g,大黄10g,冰片3g。A compound traditional Chinese medicine for treating phlebitis, which consists of the following raw materials in parts by weight: 120g of potatoes, 5g of berberine, 10g of rhubarb and 3g of borneol.
所述中药复方的制备方法,具体步骤如下:The preparation method of described Chinese medicine compound, concrete steps are as follows:
将上述马铃薯粉碎后与600mL水混合,于95℃提取25min,过滤得提取液和马铃薯渣,然后将马铃薯渣按照上述操作重复提取2次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得马铃薯提取物;Crush the above-mentioned potatoes and mix them with 600mL of water, extract at 95°C for 25 minutes, filter to obtain the extract and potato residue, then repeat the extraction of the potato residue twice according to the above operation, combine the extracts, and then concentrate the extracts under reduced pressure at 65°C To 1/10, filter the filtrate through a 0.22μm ceramic membrane to obtain the potato extract;
将上述黄连粉碎后与40mL水混合,于95℃提取45min,过滤得提取液和黄连渣,然后将黄连渣按照上述操作重复提取2次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得黄连提取物;Crush the Coptidis rhizome above and mix it with 40mL of water, extract at 95°C for 45min, filter to obtain the extract and Coptis chinensis residue, then repeat the extraction of the Coptis chinensis residue twice according to the above operation, combine the extracts, and then concentrate the extract under reduced pressure at 65°C To 1/10, filter through a 0.22μm ceramic membrane to get the filtrate to obtain the Coptidis Rhizome extract;
将上述大黄粉碎后与90mL水混合,于95℃提取50min,过滤得提取液和大黄渣,然后将大黄渣按照上述操作重复提取1次,合并提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得大黄提取物;Grind the above rhubarb and mix it with 90mL of water, extract at 95°C for 50min, filter to obtain the extract and rhubarb residue, then repeat the extraction of the rhubarb residue once according to the above operation, combine the extract, and then concentrate the extract under reduced pressure at 65°C To 1/10, filter the filtrate through a 0.22μm ceramic membrane to obtain the rhubarb extract;
将冰片粉碎,与21mL无水乙醇混合溶解,经0.22μm陶瓷膜过滤取滤液,即得冰片溶解液;Crush the borneol, mix and dissolve it with 21mL of absolute ethanol, filter the filtrate through a 0.22μm ceramic membrane, and obtain the borneol solution;
将上述马铃薯提取物、黄连提取物、大黄提取物和冰片溶解液混合后,即得中药复方。After mixing the potato extract, rhubarb extract, rhubarb extract and borneol dissolving solution, the traditional Chinese medicine compound is obtained.
实施例3Example 3
一种治疗静脉炎的中药复方,由以下重量份的原料组成:马铃薯150g,黄连3g,大黄20g,冰片5g。A compound traditional Chinese medicine for treating phlebitis, which consists of the following raw materials in parts by weight: 150g of potatoes, 3g of berberine, 20g of rhubarb and 5g of borneol.
所述中药复方的制备方法,具体步骤如下:The preparation method of described Chinese medicine compound, concrete steps are as follows:
将上述马铃薯粉碎后与1050mL水混合,于90℃提取35min,过滤得提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得马铃薯提取物;Crush the above potatoes and mix them with 1050mL of water, extract at 90°C for 35min, filter to obtain the extract, then concentrate the extract to 1/10 under reduced pressure at 65°C, and filter through a 0.22μm ceramic membrane to obtain the potato extract ;
将上述黄连粉碎后与36mL水混合,于90℃提取45min,过滤得提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得黄连提取物;Crush the above Coptis rhizome and mix it with 36mL of water, extract at 90°C for 45min, filter to obtain the extract, then concentrate the extract to 1/10 under reduced pressure at 65°C, filter through a 0.22μm ceramic membrane to get the filtrate, and obtain the Coptis chinensis extract ;
将上述大黄粉碎后与220mL水混合,于90℃提取70min,过滤得提取液,然后在65℃下减压浓缩提取液至1/10,经0.22μm陶瓷膜过滤取滤液,即得大黄提取物;Grind the rhubarb above and mix with 220mL of water, extract at 90°C for 70min, filter to obtain the extract, then concentrate the extract to 1/10 under reduced pressure at 65°C, filter the filtrate through a 0.22μm ceramic membrane, and obtain the rhubarb extract ;
将冰片粉碎,与65mL无水乙醇混合,经0.22μm陶瓷膜过滤取滤液,即得冰片溶解液;Crush the borneol, mix it with 65 mL of absolute ethanol, filter through a 0.22 μm ceramic membrane to get the filtrate, and obtain the borneol solution;
将上述马铃薯提取物、黄连提取物、大黄提取物和冰片溶解液混合后,即得中药复方。After mixing the potato extract, rhubarb extract, rhubarb extract and borneol dissolving solution, the traditional Chinese medicine compound is obtained.
实施例4Example 4
一种中药复方水凝胶的制备方法如下:A preparation method of Chinese medicine compound hydrogel is as follows:
配制相1:甘羟铝0.14%、NOVETAC P55N 0.5%、EDTA 0.12%、NOVETAC P46N 5%,甘油25%;Preparation Phase 1: Aluminum Glycol 0.14%, NOVETAC P55N 0.5%, EDTA 0.12%, NOVETAC P46N 5%, Glycerin 25%;
配制相2:石酒酸0.22%、DMDMH 0.2%、纯净水50%;Preparation phase 2: tartaric acid 0.22%, DMDMH 0.2%, purified water 50%;
配制相3:酒精0.45%、薄荷脑0.25%;Preparation phase 3: 0.45% alcohol, 0.25% menthol;
配制相4:实施例1制备得到的中药复方余量。Preparation phase 4: the balance of the traditional Chinese medicine compound prepared in Example 1.
将配制相2与配制相4混合均匀后加入配制相1,搅拌均匀,然后加入配制相3,快速搅拌形成胶体,完成后进入涂布机制成水凝胶贴备用。Mix the preparation phase 2 and the preparation phase 4 evenly, then add the preparation phase 1, stir evenly, then add the preparation phase 3, stir quickly to form a colloid, and enter the coating machine to make a hydrogel paste for later use.
使用:患者症状出现时立刻敷贴1次,1次3小时。Usage: When the patient's symptoms appear, apply it once for 3 hours.
实施例5Example 5
一种中药复方水凝胶的制备方法如下:A preparation method of Chinese medicine compound hydrogel is as follows:
配制相1:甘羟铝0.14%、NOVETAC P55N 0.5%、EDTA 0.12%、NOVETAC P46N 5%,甘油25%;Preparation Phase 1: Aluminum Glycol 0.14%, NOVETAC P55N 0.5%, EDTA 0.12%, NOVETAC P46N 5%, Glycerin 25%;
配制相2:石酒酸0.22%、DMDMH 0.2%、纯净水50%;Preparation phase 2: tartaric acid 0.22%, DMDMH 0.2%, purified water 50%;
配制相3:酒精0.45%、薄荷脑0.25%;Preparation phase 3: 0.45% alcohol, 0.25% menthol;
配制相4:实施例2制备得到的中药复方余量。Preparation phase 4: the balance of the traditional Chinese medicine compound prepared in Example 2.
将配制相2与配制相4混合均匀后加入配制相1,搅拌均匀,然后加入配制相3,快速搅拌形成胶体,完成后进入涂布机制成水凝胶贴备用。Mix the preparation phase 2 and the preparation phase 4 evenly, then add the preparation phase 1, stir evenly, then add the preparation phase 3, stir quickly to form a colloid, and enter the coating machine to make a hydrogel paste for later use.
使用:患者症状出现时立刻敷贴1次,1次3小时。Usage: When the patient's symptoms appear, apply it once for 3 hours.
实施例6Example 6
一种中药复方水凝胶的制备方法如下:A preparation method of Chinese medicine compound hydrogel is as follows:
配制相1:甘羟铝0.14%、NOVETAC P55N 0.5%、EDTA 0.12%、NOVETAC P46N 5%,甘油25%;Preparation Phase 1: Aluminum Glycol 0.14%, NOVETAC P55N 0.5%, EDTA 0.12%, NOVETAC P46N 5%, Glycerin 25%;
配制相2:石酒酸0.22%、DMDMH 0.2%、纯净水50%;Preparation phase 2: tartaric acid 0.22%, DMDMH 0.2%, purified water 50%;
配制相3:酒精0.45%、薄荷脑0.25%;Preparation phase 3: 0.45% alcohol, 0.25% menthol;
配制相4:实施例3制备得到的中药复方余量。Preparation phase 4: the balance of the traditional Chinese medicine compound prepared in Example 3.
将配制相2与配制相4混合均匀后加入配制相1,搅拌均匀,然后加入配制相3,快速搅拌形成胶体,完成后进入涂布机制成水凝胶贴备用。Mix the preparation phase 2 and the preparation phase 4 evenly, then add the preparation phase 1, stir evenly, then add the preparation phase 3, stir quickly to form a colloid, and enter the coating machine to make a hydrogel paste for later use.
使用:患者症状出现时立刻敷贴1次,1次3小时。Usage: When the patient's symptoms appear, apply it once for 3 hours.
对比例1Comparative example 1
本对比例与实施例4的区别在于,本对比例的水凝胶是将实施例4中所述的中药复方替换为等质量的马铃薯提取物,马铃薯提取物的制备方法与实施例1相同,水凝胶的制备方法中将中药复方替换为马铃薯提取物,其它步骤相同。The difference between this comparative example and Example 4 is that the hydrogel of this comparative example replaces the Chinese medicine compound described in Example 4 with an equal-quality potato extract, and the preparation method of the potato extract is the same as in Example 1. In the preparation method of the hydrogel, the traditional Chinese medicine compound is replaced by the potato extract, and other steps are the same.
使用:患者症状出现时立刻敷贴1次,1次3小时。Usage: When the patient's symptoms appear, apply it once for 3 hours.
对比例2Comparative example 2
本对比例与实施例5的区别在于,本对比例的水凝胶是将实施例5中的中药复方替换为大黄提取物和黄连提取物,其中大黄提取物和黄连提取物总质量与中药复方相同,大黄提取物与黄连提取物的质量比为3:2。大黄提取物和黄连提取物的制备方法与实施例1相同,水凝胶的制备方法中将中药复方替换为大黄提取物、黄连提取物,其它步骤相同。The difference between this comparative example and Example 5 is that the hydrogel of this comparative example replaces the Chinese medicine compound in Example 5 with rhubarb extract and Coptis chinensis extract, wherein the total mass of rhubarb extract and Coptis chinensis extract is the same as that of the Chinese medicine compound Same, the mass ratio of rhubarb extract and coptis extract is 3:2. The preparation method of rhubarb extract and coptis extract is the same as that of Example 1. In the preparation method of the hydrogel, the traditional Chinese medicine compound is replaced by rhubarb extract and coptis extract, and other steps are the same.
使用:患者症状出现时立刻敷贴1次,1次3小时。Usage: When the patient's symptoms appear, apply it once for 3 hours.
对比例3Comparative example 3
本对比例为新鲜马铃薯切片:选新鲜土豆,清水洗净,去皮,将土豆切片,每片0.5cm厚。This comparative example is fresh potato slices: choose fresh potatoes, wash them with clear water, peel them, and slice the potatoes with a thickness of 0.5 cm per slice.
根据静脉炎大小贴在皮肤上,贴敷面积略大于静脉炎皮肤面积。用保鲜膜呈圆形包裹住患肢,松紧适宜,不可过紧,以免引起局部皮肤的血运。Stick it on the skin according to the size of the phlebitis, and the sticking area is slightly larger than the skin area of the phlebitis. Wrap the affected limb with a plastic wrap in a circular shape, the tightness is appropriate, not too tight, so as not to cause blood supply to the local skin.
使用:患者症状出现时立刻敷贴6次,1次1小时。Usage: Immediately apply 6 times when the patient's symptoms appear, 1 time for 1 hour.
对比例4Comparative example 4
本对比例采用50%的硫酸镁溶液,操作前用温水清洁患者皮肤并将三层纱布覆盖于患处,采用50%的硫酸镁溶液浸透纱布,以不滴水为宜,同时用保鲜膜缠绕纱布,使硫酸镁溶液不易蒸发。This comparative example adopts 50% magnesium sulfate solution, cleans the patient's skin with warm water and covers the affected part with three layers of gauze before the operation, adopts 50% magnesium sulfate solution to soak the gauze, it is advisable not to drip, and wraps the gauze with plastic wrap at the same time, Make the magnesium sulfate solution not easy to evaporate.
使用:患者症状出现时立刻湿敷2次,1次3小时。Use: Immediately wet compress 2 times when the patient's symptoms appear, 1 time for 3 hours.
试验例1Test example 1
选取化疗性与机械性静脉炎患者进行药物活性试验,其诊断及评价方法等具体如下:Patients with chemotherapeutic and mechanical phlebitis were selected for drug activity test. The diagnosis and evaluation methods are as follows:
1.临床患者资料1. Clinical patient data
选择化疗性和机械性静脉炎的患者111例,年龄35~78岁,平均年龄(52±10.1)岁。涉及疾病包括:肝癌,胃癌,胰腺癌,胆囊癌,结肠癌,肝硬化,消化道出血,胰腺炎,胆囊炎,冠心病,糖尿病。使用的药物包括:环磷酰胺、紫杉醇等化疗药物,硫酸依替米星、头孢哌酮舒巴坦钠等抗生素,补液治疗等。Select chemotherapy and mechanical phlebitis in 111 patients, aged 35 to 78 years, with an average age of (52 ± 10.1) years. Diseases involved include: liver cancer, gastric cancer, pancreatic cancer, gallbladder cancer, colon cancer, liver cirrhosis, gastrointestinal bleeding, pancreatitis, cholecystitis, coronary heart disease, diabetes. The drugs used include: chemotherapy drugs such as cyclophosphamide and paclitaxel, antibiotics such as etimicin sulfate, cefoperazone and sulbactam sodium, and fluid replacement therapy.
2.采用随机数字表法,空白组6例,其余每组15例,随机分组及治疗方法如下:2. Using the random number table method, 6 cases in the blank group, and 15 cases in each other group, the random grouping and treatment methods are as follows:
空白组:不做任何处理。Blank group: no treatment.
实施例4:敷贴1次,1次3小时。Embodiment 4: Apply once for 3 hours.
实施例5:敷贴1次,1次3小时。Embodiment 5: Apply once for 3 hours.
实施例6:敷贴1次,1次3小时。Embodiment 6: Apply once for 3 hours.
对比例1:敷贴1次,1次3小时。Comparative example 1: Apply once for 3 hours.
对比例2:敷贴1次,1次3小时。Comparative example 2: Apply once for 3 hours.
对比例3:敷贴6次,1次1小时。Comparative example 3: apply 6 times, 1 hour per time.
对比例4:湿敷2次,1次3小时。Comparative example 4: Wet compress 2 times, 3 hours each time.
3.评价指标3. Evaluation indicators
(1)VAS评分标准(1) VAS Scoring Criteria
采用视觉模拟评分法:一条长100mm的标尺,一端标示“无痛”,另一端标示“最剧烈的疼痛”,患者根据疼痛的强度标定相应的位置。临床评定以“0~2”分表示“优”,“3~5”分表示“良”,“6~8”分表示“可”,>“8”分表示“差”。The visual analog scale method is used: a 100mm long scale is marked with "no pain" at one end and "severe pain" at the other end, and the patient marks the corresponding position according to the intensity of pain. In clinical evaluation, "0-2" indicates "excellent", "3-5" indicates "good", "6-8" indicates "fair", and >"8" indicates "poor".
(2)平均疼痛消退时间(2) Average pain subside time
从外敷至疼痛完全消失的平均时间。The average time from external application to the complete disappearance of pain.
(3)平均红肿消退时间(3) Average time for redness and swelling to subside
丛外敷至红肿完全消失的平均时间。The average time from external application of the plexus to the complete disappearance of redness and swelling.
(4)疗效评价标准(4) Evaluating Criteria for Efficacy
痊愈:临床症状消失,干预后患处静脉血管变软、血管弹性恢复,患肢及患处无压痛、红肿;显效:干预后患处血管变软,有轻微压痛及红肿;有效:干预后患处血管较干预前稍变软,红肿及疼痛稍减轻或无变化,病患血管仍呈条索状;无效:干预后病患处血管无变化或加重,疼痛程度无变化或加重。总有效率=(痊愈例数+有效例数+显效例数)/总例数×100%。Healed: clinical symptoms disappeared, the veins in the affected area softened and the elasticity of blood vessels recovered after the intervention, and there was no tenderness, redness and swelling in the affected limbs and affected areas; markedly effective: the blood vessels in the affected area became soft after the intervention, with slight tenderness and redness; effective: the blood vessels in the affected area were softer after the intervention The anterior part becomes softer, the redness and pain are slightly reduced or unchanged, and the blood vessels of the patient are still in the shape of cords; invalid: the blood vessels of the affected part remain unchanged or aggravated after the intervention, and the degree of pain remains unchanged or aggravated. Total effective rate=(number of cured cases+number of effective cases+number of markedly effective cases)/total number of cases×100%.
4.结果4. Results
根据上述诊断及评价标准,将上述实施例1~3、对比例1~2所述水凝胶、对比例3新鲜马铃薯切片、对比例4的50%的硫酸镁溶液用于治疗化疗性与机械性静脉炎患者,以不做任何处理作为空白组,其结果如下表1、表2和表3,贴敷实施例1的中药复方水凝胶前后的治疗情况见图1。According to the above diagnosis and evaluation criteria, the hydrogels described in the above-mentioned Examples 1-3, Comparative Examples 1-2, the fresh potato slices of Comparative Example 3, and the 50% magnesium sulfate solution of Comparative Example 4 are used for the treatment of chemotherapeutic and mechanical Patients with chronic phlebitis, without any treatment as blank group, the results are shown in Table 1, Table 2 and Table 3, and the treatment situation before and after applying the Chinese medicine compound hydrogel of Example 1 is shown in Figure 1.
表1平均疼痛程度、平均疼痛消退时间和平均红肿消退时间情况Table 1 The average pain degree, the average pain subsidence time and the average redness subsidence time
由表1的结果表明,与对比例相比,通过采用本发明的实施例1~3的中药复方水凝胶治疗静脉炎后,患者的疼痛程度明显减轻,且平均疼痛消退时间、平均红肿消退时间明显缩短,患者使用后体感好、疼痛减轻明显、干净、操作方便,且无不良反应。The results in Table 1 show that, compared with the comparative example, after treating phlebitis by using the Chinese medicine compound hydrogel of Examples 1 to 3 of the present invention, the pain degree of the patient is significantly reduced, and the average pain subsides time, and the average redness subsides. The time is significantly shortened, the patient feels better after using it, the pain is relieved obviously, it is clean, easy to operate, and has no adverse reactions.
表2疗效评价情况(以3h疗效为观察时间点)Table 2 Evaluation of curative effect (with 3h curative effect as the observation time point)
由表2可知,与对比例相比,本发明的中药复方的有效率高达100%。It can be known from Table 2 that compared with the comparative example, the effective rate of the Chinese medicine compound of the present invention is as high as 100%.
表3不良反应情况Table 3 Adverse reactions
由表3可知,本发明的中药复方在治疗静脉炎时并无不良反应,安全性高。As can be seen from Table 3, the Chinese medicine compound of the present invention has no adverse reaction when treating phlebitis, and has high safety.
由图1的结果可知,敷贴前静脉穿刺处出现红肿、疼痛,贴敷本发明实施例1的中药复方水凝胶1次,共3h,经24小时后观察,红肿及疼痛消失。It can be seen from the results in Fig. 1 that redness, swelling and pain appeared at the venipuncture site before application, and the Chinese medicine compound hydrogel of Example 1 of the present invention was applied once for a total of 3 hours. After 24 hours of observation, the redness and pain disappeared.
在治疗过程中,实施例1~3的中药复方水凝胶均有良好疗效,3小时内达到消肿止痛的效果,而对比例1~2虽略有疗效,但疗效远低于实施例1~3的中药复方水凝胶。对比例4中硫酸镁由于需要保鲜膜缠绕,严重影响患者的活动和生活质量,患者依从性差,且存在一定的皮肤刺激性,有3例患者出现皮肤瘙痒,2例患者出现疼痛加重,对比例3中马铃薯切片需保鲜膜缠绕固定,加之更换马铃薯切片频次高,同样严重影响了患者的活动与生活质量,依从性差,且有2例患者出现瘙痒。During the course of treatment, the traditional Chinese medicine compound hydrogels of Examples 1-3 all had good curative effects, and achieved the effect of reducing swelling and relieving pain within 3 hours, while Comparative Examples 1-2 had a slight curative effect, but the curative effect was far lower than that of Example 1. ~3 traditional Chinese medicine compound hydrogels. In comparative example 4, magnesium sulfate needs to be wrapped with plastic wrap, which seriously affects the patient's activities and quality of life. The patient's compliance is poor, and there is a certain degree of skin irritation. There are 3 patients with skin itching, and 2 patients with aggravated pain. The potato slices in 3 need to be wrapped and fixed with plastic wrap, and the frequency of replacing potato slices is high, which also seriously affects the activities and quality of life of the patients, and the compliance is poor, and 2 patients developed itching.
综上,本发明所述治疗静脉炎的中药复方,与马铃薯切片和硫酸镁湿敷对比,具有非常显著的减轻疼痛和消肿的效果,无不良反应,患者依从性好,还具有更方便的操作便捷性、换药频次少、作用时间长、不易污染衣物、价格低廉、体感好等优点,本发明通过对马铃薯、黄连、大黄和冰片进行合理配伍,利用原料之间的协同作用,从而有效地预防和治疗静脉炎。In conclusion, the traditional Chinese medicine compound for treating phlebitis of the present invention, compared with potato slices and magnesium sulfate wet compress, has a very significant effect of relieving pain and detumescence, has no adverse reactions, and has good patient compliance, and has a more convenient It has the advantages of convenient operation, less frequency of dressing change, long action time, not easy to contaminate clothes, low price, good body feeling, etc. The present invention makes use of the synergistic effect between the raw materials to effectively Prevention and treatment of phlebitis.
典型案例Typical Case
王某,男,52岁,吉林省长春人。静脉输液后穿刺处出现红、肿、热、痛。使用本发明中药复方水凝胶贴1小时后,穿刺处局部红肿热痛消失。Wang, male, 52 years old, is from Changchun, Jilin Province. Redness, swelling, heat, and pain appear at the puncture site after intravenous infusion. After using the Chinese medicine compound hydrogel paste of the present invention for 1 hour, the local redness, swelling, heat and pain at the puncture site disappeared.
刘某,女,33岁,辽宁省沈阳人。静脉输液10余日后出现穿刺点红、肿、热、痛。使用本发明中药复方水凝胶贴2小时后,穿刺处局部红肿热痛消失。Liu, female, 33 years old, was born in Shenyang, Liaoning Province. More than 10 days after the intravenous infusion, the puncture point was red, swollen, hot, and painful. After using the Chinese medicine compound hydrogel paste of the present invention for 2 hours, the local redness, swelling, heat and pain at the puncture site disappeared.
闫某,女,65岁,吉林省敦化人。静脉输液20余日后出现穿刺点红、肿、热、痛。使用本发明中药复方水凝胶贴1小时后,穿刺处局部红肿热痛消失。Yan, female, 65 years old, was born in Dunhua, Jilin Province. After more than 20 days of intravenous infusion, the puncture point was red, swollen, hot, and painful. After using the traditional Chinese medicine compound hydrogel paste of the present invention for 1 hour, the local redness, swelling, heat and pain at the puncture site disappeared.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210231494.9A CN114470067B (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210231494.9A CN114470067B (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114470067A CN114470067A (en) | 2022-05-13 |
CN114470067B true CN114470067B (en) | 2023-07-04 |
Family
ID=81487145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210231494.9A Active CN114470067B (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114470067B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919896A (en) * | 2014-04-23 | 2014-07-16 | 文成县刀锋科技有限公司 | Externally applied traditional Chinese medicine preparation for treating phlebitis |
CN104815041B8 (en) * | 2015-05-06 | 2018-06-22 | 青岛市市立医院 | For treating Chinese medicine composition of PICC phlebitis and its preparation method and application |
CN105168391A (en) * | 2015-10-16 | 2015-12-23 | 宋金燕 | Cataplasm for treating infusion phlebitis and preparation method thereof |
-
2022
- 2022-03-10 CN CN202210231494.9A patent/CN114470067B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114470067A (en) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552501B (en) | External traditional Chinese medicine composition for treating leukoplakia vulvae | |
CN104435449B (en) | A kind of pharmaceutical composition of antiatherosclerosis and its application | |
CN109316555A (en) | A kind of traditional Chinese medicine for outer use and preparation method thereof promoting chronic ulcer of skin wound healing | |
CN114470067B (en) | Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof | |
CN103877454A (en) | Chinese traditional medicine plaster special for local anaesthesia and analgesia and preparation method of plaster | |
CN105456498A (en) | Traditional Chinese medicinal preparation for treating diabetic foot ulcer | |
CN104706919B (en) | A kind of pharmaceutical composition for the treatment of ulcer in body surface | |
CN103977113A (en) | Traditional Chinese medicament for treating diabetic foot | |
CN103655854B (en) | Treatment venous transfusion causes phlebitic application compress and using method | |
CN108114090B (en) | A Chinese medicinal composition for treating hemorrhoid, burn and scald | |
CN108403797B (en) | Abdomen warming patch and preparation method thereof | |
CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
CN107496567B (en) | Traditional Chinese medicine preparation for treating diabetic foot disease and preparation method thereof | |
CN107812091B (en) | Traditional Chinese medicine preparation for treating phlebitis caused by chemotherapeutic drugs and preparation method thereof | |
CN105250568A (en) | Medicinal composition for treating scalds and burns and preparation method thereof | |
CN105327290B (en) | A kind of external application Chinese medicine and preparation method thereof for treating diabetic gangrene | |
CN105168503B (en) | It is a kind of to be used to prevent external medicine composition of radiodermatitis and preparation method thereof | |
CN109432198B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN112603958B (en) | A kind of traditional Chinese medicine composition for treating myofasculitis, preparation method and application thereof | |
CN110464774B (en) | Compound propranolol hydrochloride oral liquid for treating infantile hemangioma | |
CN102940677A (en) | Medicine composition for treating diabetic foot | |
CN102920877A (en) | Chinese medicament for treating haemorrhoids | |
CN111939203B (en) | Traditional Chinese medicine ointment preparation for treating diabetic foot and preparation method thereof | |
CN101869623B (en) | Medicament for treating trichoepithelioma and preparation method thereof | |
CN101607069B (en) | Chinese traditional medicine for treating phlebitis, old lower extremity venous ulcer and venous purpura disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |